Immunological Techniques Radioimmunoassay (RIA)

Total Page:16

File Type:pdf, Size:1020Kb

Immunological Techniques Radioimmunoassay (RIA) Regular Office Hours: Tuesdays 11-12 Extra office hours: Wed, Feb 7 12-1pm Thurs, Feb 8 11am-12 Midterm Fri, Feb 9 2-4pm I WILL NOT BE HOLDING OFFICE HOURS ON TUESDAY Feb 13!! Extra Office Hours Dina, Tim, and I encourage all confused students to come to our office hours and discussion sections so we can try to help un-confuse you. Take No class on Tuesday Feb 13. First midterm: Thurs Feb 15 at 6pm in 155 Dwinelle (not 2050 VLSB as listed in the original schedule). Midterm will focus on material covered in lectures and will be designed to be taken in 90 min. (We have the room till 8pm.) The GSIs will conduct a review session in our regular class period on Thursday Feb 15. The extraordinary specificity of Immunological Techniques antibodies for their antigens, and the ability to generate polyclonal and monoclonal antibodies to virtually anything, makes them fantastically Monoclonal Antibodies useful reagents for detecting and quantitating substances. Radioimmune Assay (RIA) A large number of different assays have been developed to detect antigens based Enyzme Linked Immune Sorbant Assay (ELISA) on antibody binding that can be used in in fluids, tissues, or cells. Western blot Immunoprecipitation Immunofluorescence Flow cytometry Expression cloning Radioimmunoassay (RIA) •1960 Yalow and Berson (Nobel Prize) •Very sensitive: can detect material present at concentrations of <0.001 micrograms/ml. •Takes advantage of protein binding to Cpm plastic of tissue culture dish. •Generate standard curve with known RIA to detect amounts of unlabeled antigen •Measure unknown using standard curve. hepatitis Labeled antigen detects hepatitis virus in 1 microliter Amount unlabeled Antigen Unlabeled of blood. antigen Used for screening blood for transfusions. 1 Enzyme-linked immune sorbant Variations of the ELISA method assay (ELISA) Capture Add second specific antigen using antibody-enzyme Colorometric plate-bound conjugate assay antibody Detection by secondary antibodies conjugated to enzymes (alkaline phosphatase, horse radish peroxidase, β-galactosidase). Break- down of substrate by enzyme produces a visible color. ELISA based pregnancy test 2 Real life example of use of ELISA assay (from your reading assignment: “A Toll-like receptor recognizes • The ELISPOT assay bacterial DNA” Hemmi 2000 Nature v408 p 740 Figure 3b) can be used to Isolate macrophage from wild type and TLR9 mutant mice. Stimulate with CpG (mammalian DNA is methylated at CpG residues, and so differs from determine the unmethylated bacterial DNA) Peptidoglygan (PGN) and Lipopolysaccaride (LPS) trigger innate immune number of cells responses through other TLRs and serve as positive controls. Measure cytokine within a sample that production (TNF-α) in culture supernatants by ELISA are secreting a particular cytokine. Concentration of the cytokine TNF-α as measured by ELISA Western Blot SDS-polyacrylamide gel electrophoresis to separate a complex mixture of proteins based on their molecular weight. Transfer proteins from gel to a membrane sheet. Gel electrophoresis separates proteins by size, so Western blot not only provides quantitation, but also provides information about the molecular weight of antigen. After transferring proteins from gel to a membrane sheet, use labeled antibodies to your protein of interest to detect the relevant band. Labeled antibodies bind to band containing your protein of interest. Detect labeled antibody using colorimentic assay. 3 Immunoprecipitation Immunoprecipitation: variations of the method. Anti- + antibody Protein A or Protein G Protein A and Protein G: bacterial cell wall proteins that binds to Ig. Magnetic beads coupled to antibodies can be used to isolate proteins from solution, or cells from a suspension. And check out “A Toll-like receptor recognizes bacterial DNA” Hemmi 2000 Nature v408 p 740 Figure 3 f and g For real-life examples of Immunoprecipitations and Western blots to analyze TLR signaling intermediates in wild type and TLR9- macrophage in response to different TLR agonists. Immunoaffinity Chromatography Immunofluorescence Fluorochrome-conjugated secondary-antibody (anti-Ig antibody) Fluorochrome-conjugated specific antibody Unconjugated specific antibody direct indirect 4 Immunofluorescence can provide spatial information about cells or molecules that react with antibodies. Anti-IgM stain of B cells Mixture of cells labeled with fluorescent antibodies Immunological Techniques Flow cytometry can be used to Monoclonal Antibodies determine the number of cells Radioimmune Assay (RIA) within a sample that react with a Enyzme Linked Immune Sorbant Assay (ELISA) particular Western blot antibody (or Immunoprecipitation antibodies) Flow cytometry Expression cloning 1 parameter histograms: Analysis of cells stained with labeled antibodies Flow cytometric Dot plots Contour plots Cell < 1 % Unstained cells analysis number positive (negative control) of cells stained with 2 different labeled Number Fluorescence intensity of antibodies cells Cell 30% ) 2 parameter dot plot: number positive n Stained e e r cells g ( 20% histograms y 20% t i Green s “double n only e Positive” Fluorescence intensity (red) t n i e c n e c Number s e of Cell 40% r 10% o 50% cells number positive u Stained l “double red F cells negative” only Fluorescence intensity (red) Fluorescence intensity (green) Amt. IgD 5 The Power of Flow Cytometry Real life example of use of flow cytometry Quantitative: (from your reading assignment: “A Toll-like receptor recognizes Accurately determine relative fluorescent levels (proteins bacterial DNA” Hemmi 2000 Nature v408 p 740 Figure 3d) levels) on individual cells. Isolate macrophage from wild type and TLR9 mutant mice. Accurately determine the number of fluorescent cells within Stimulate with CpG (or LPS as positive control). Examine expression of activation markers by flow cytometry. a population. CD40 CD80 CD86 MHC-II Sensitive: Wild type Analysis can be performed with <104 cells. Flexible: TLR9-/- Number of cells Fluorescent labeled antibodies specific for many cell surface proteins are readily available. Can simultaneously Fluorescence intensity Note: CD40, CD90, CD86, and MHC-II are all important for T cell activation stain for >4 markers. by macrophage (innate immunity stimulating adaptive immunity). The generation of monoclonal antibodies Flow cytometry can be used to identify different kinds of leukemia. specific for cell surface proteins, coupled (“CD” nomenclature) with flow cytometry, provides a powerful tool for identifying different lymphocyte populations. Ultrasonic nozzle vibrator Fluorescence Cell suspension Sheath fluid Cell- activated Cell- sorting sorting Drop-charging (FACS) signal using the using the flow laser flow cytometer cytometer Cell collector Cell collector Flask for undeflected droplets 6 Magnetic beads coupled to antibodies can also Expression cloning genes in E. be used to purify cells (an alternative to FACS, that is especially useful for processing larger coli numbers of cells.) Cell expressing Purified cDNA cDNA library in Protein of interest mRNA Bacterial expression vector Bacterial Colonies, Each Bacteria Expressing expressing cDNA of Flow cytometry is used here to monitor the composition One Specific cDNA interest of the cell sample before and after separation. antibody A a result of V(D)J recombination every mature B cell expresses a unique antibody. Expression Encounter with an antigen leads to clonal expansion of B cells with a particular Cloning specificity. •Make antiserum against gene-product of interest •Make cDNA expression library from cell line expressing gene •Transfect library into cell line which does not normally express gene-product •Select cells expressing product by antibody-binding •Recover cDNA expression vector •Repeat. Recover. Sequence. Victory! Where we have been and where we are going Innate Immunity V(D)J Recombination Antibodies and antigens I (emphasis on antibody structure) Discovery of Ig gene rearrangements Antibodies and antigens II (emphasis on antigen-antibody binding interactions) Structure of antibody genes (RSS) Techniques based on antibodies Role of RAG proteins and DNA repair machinery V(D)J recombination B cell development and function 7 HV3 HV1 HV2 The puzzle of antibody diversity • Limitless array of Ig sequences (too large to be encoded in genome) • Variation limited to V domain. • Identical V segment could be associated with two different C regions (myeloma Variability protein with γ and µ chains) of Ig • Germ-line vs somatic variation models • Dreyer and Bennett (1965) the 2 gene model; a violation of the “one gene, one Sequences polypeptide” rule • 1976: the emerging tools of molecular biology open the way for the breakthrough. Review of Southern blot method The breakthrough paper Restriction endonucleases cleave at specific sequences in DNA and can be used to generate a physical map of DNA. (e.g. EcoRI cleaves at the sequence: 5’-GAATTC-3’) Surprising Southern blot Surprising Southern blot 3 3 a a 1 2 1 2 m m a a a a o o l l m m m m e e n n o o o o y y l l l l e e r r e e e e m m e n e n e e l i l i y y y y v v p k p k i i l m m s s l m m s s Jκ1Jκ2Jκ3Jκ4 Cκ Vκ1 Vκ 2 Cκ probe 8 Detecting Ig gene rearrangement using Southern blot V(D)J Recombination Discovery of Ig gene rearrangements Structure of antibody genes (RSS) Evidence for role of RAG proteins and DNA repair machinery Multigene organization of Ig genes: Multigene organization of Ig genes: light chain genes heavy chain genes VK gene segments JK gene segments VH gene segments DH gene segments JH gene segments
Recommended publications
  • Comparison of Immunohistochemistry with Immunoassay (ELISA
    British Journal of Cancer (1999) 79(9/10), 1534–1541 © 1999 Cancer Research Campaign Article no. bjoc.1998.0245 Comparison of immunohistochemistry with immunoassay (ELISA) for the detection of components of the plasminogen activation system in human tumour tissue CM Ferrier1, HH de Witte2, H Straatman3, DH van Tienoven2, WL van Geloof1, FJR Rietveld1, CGJ Sweep2, DJ Ruiter1 and GNP van Muijen1 Departments of 1Pathology, 2Chemical Endocrinology and 3Epidemiology, University Hospital Nijmegen, PO Box 9101, 6500 HB Nijmegen, The Netherlands Summary Enzyme-linked immunosorbent assay (ELISA) methods and immunohistochemistry (IHC) are techniques that provide information on protein expression in tissue samples. Both methods have been used to investigate the impact of the plasminogen activation (PA) system in cancer. In the present paper we first compared the expression levels of uPA, tPA, PAI-1 and uPAR in a compound group consisting of 33 cancer lesions of various origin (breast, lung, colon, cervix and melanoma) as quantitated by ELISA and semi-quantitated by IHC. Secondly, the same kind of comparison was performed on a group of 23 melanoma lesions and a group of 28 breast carcinoma lesions. The two techniques were applied to adjacent parts of the same frozen tissue sample, enabling the comparison of results obtained on material of almost identical composition. Spearman correlation coefficients between IHC results and ELISA results for uPA, tPA, PAI-1 and uPAR varied between 0.41 and 0.78, and were higher for the compound group and the breast cancer group than for the melanoma group. Although a higher IHC score category was always associated with an increased median ELISA value, there was an overlap of ELISA values from different scoring classes.
    [Show full text]
  • Immunoassay - Elisa
    IMMUNOASSAY - ELISA PHUBETH YA-UMPHAN National Institute of Health, Department of Medical Sciences 0bjective After this presentation, participants will be able to Explain how an ELISA test determines if a person has certain antigens or antibodies . Explain the process of conducting an ELISA test. Explain interactions that take place at the molecular level (inside the microtiter well) during an ELISA test. Outline - Principal of immunoassay - Classification of immunoassay Type of ELISA - ELISA ELISA Reagents General - Applications Principal of ELISA ELISA workflow What is immunoassay? Immunoassays are bioanalytical methods that use the specificity of an antigen-antibody reaction to detect and quantify target molecules in biological samples. Specific antigen-antibody recognition Principal of immunoassay • Immunoassays rely on the inherent ability of an antibody to bind to the specific structure of a molecule. • In addition to the binding of an antibody to its antigen, the other key feature of all immunoassays is a means to produce a measurable signal in response to the binding. Classification of Immunoassays Immunoassays can be classified in various ways. Unlabeled Labeled Competitive Homogeneous Noncompetitive Competitive Heterogeneous Noncompetitive https://www.sciencedirect.com/science/article/pii/S0075753508705618 Classification of Immunoassays • Unlabeled - Immunoprecipitation • Labeled Precipitation of large cross-linked Ag-Ab complexes can be visible to the naked eyes. - Fluoroimmnoassay (FIA) - Radioimmunoassay (RIA) - Enzyme Immunoassays (EIA) - Chemiluminescenceimmunoassay(CLIA) - Colloidal Gold Immunochromatographic Assay (ICA) https://www.creative-diagnostics.com/Immunoassay.htm Classification of Immunoassays • Homogeneous immunoassays Immunoassays that do not require separation of the bound Ag-Ab complex. (Does not require wash steps to separate reactants.) Example: Home pregnancy test. • Heterogeneous immunoassays Immunoassays that require separation of the bound Ag-Ab complex.
    [Show full text]
  • Laboratory Techniques Used for Immunological Laboratory Methods
    Laboratory techniques used for Immunological laboratory methods Dr. Tatiana Jones, MD, PhD NCC How to Make Serial Dilutions? Interpretation can be made differently depending on the nature of test. For example, if we need to figure out in what sample the concentration of the antibody or antigen is higher, we will go by TITER, which is the lowest serial dilution (let’s say that it is 1:32 in the picture on the left) that gives us positive result. This mean that even diluted 32 times sample is still capable of reacting. The other scenario when we are interpreting quantitative assays, such as ELISA. In this case we need to match results of our samples to known concentrations of STANDARD and MULTIPLY be our dilution factor. What is Antibody Titer? An antibody titer is a measurement of how much antibody an organism has produced that recognizes a particular antigen. Titer is expressed as the inverse of the greatest dilution that still gives a positive result. ELISA is a common means of determining antibody titers. How to Determine Antibody Titer? Where we can use Indirect Coombs test detects the presence of anti-Rh antibodies in blood serum. A patient might be reported to have an "indirect Antibody Titer? Coombs titer" of 16. This means that the patient's serum gives a positive indirect Coombs test at any dilution down to 1/16 (1 part serum to 15 parts diluent). At greater dilutions the indirect Coombs test is negative. If a few weeks later the same patient had an indirect Coombs titer of 32 (1/32 dilution which is 1 part serum to 31 parts diluent), this would mean that more anti-Rh antibody was made, since it took a greater dilution to eradicate the positive test.
    [Show full text]
  • An Enzyme-Linked Immunosorbent Assay (ELISA) for Pantothenate
    Utah State University DigitalCommons@USU All Graduate Theses and Dissertations Graduate Studies 5-1981 An Enzyme-Linked Immunosorbent Assay (ELISA) for Pantothenate Allen H. Smith Utah State University Follow this and additional works at: https://digitalcommons.usu.edu/etd Part of the Biochemistry Commons Recommended Citation Smith, Allen H., "An Enzyme-Linked Immunosorbent Assay (ELISA) for Pantothenate" (1981). All Graduate Theses and Dissertations. 5295. https://digitalcommons.usu.edu/etd/5295 This Thesis is brought to you for free and open access by the Graduate Studies at DigitalCommons@USU. It has been accepted for inclusion in All Graduate Theses and Dissertations by an authorized administrator of DigitalCommons@USU. For more information, please contact [email protected]. AN ENZYME- LINKED ThltviUNOSORBE!'IT ASSAY (ELISA) FOR PANTOTHENATE by Allen H. Smith A thesis submitted in partial fulfillment of the requirements for the degree of MASTER OF SCIENCE in Biochemistry UTAH STATE UNIVERSITY Logan, Utah 1981 ii ACKNOWLEDGEMENTS To Dr. R. G. Hansen, to Dr. B. W. Wyse, to Carl Wittwer, to Jack Brown, to Jan Pearson, to Nedra Christensen, to all those who have made this experience one of tremendous growth, I express my thanks. I express appreciation to the United States Department of Agriculture, under Grant #5901-0410-9-0288-0 with Utah State University, for financial support. Finally, I express thanks to my parents, who have come to realize that graduate school is also a part of life. Allen H. Smith "iii TABLE OF CONTENTS Page ACKNOWLEDGEMENTS ii LIST OF TABLES . vi LIST OF FIGURES. vii · ABSTRACT .. ix INTRODUCTION 1 REVIEW OF LITERATURE 4 Pantothenate Assays .
    [Show full text]
  • Detection of Virus-Specific Immunoglobulins Using a Doubly Labeled Fluorescein- 125I Antibody A
    JOURNAL OF CLINICAL MICROBIOLOGY, June 1976, p. 637-639 Vol. 3, No. 6 Copyright © 1976 American Society for Microbiology Printed in U.S.A. Detection of Virus-Specific Immunoglobulins Using a Doubly Labeled Fluorescein- 125I Antibody A. J. PARKINSON* AND J. KALMAKOFF Department ofMicrobiology, University of Otago, Dunedin, New Zealand Received for publication 17 February 1976 Commercially prepared fluorescein-labeled antihuman antibodies were la- beled with 125I and used to compare specific herpes simplex virus antibody titers as determined by indirect fluorescent antibody and radioimmunoassay tech- niques. Total virus-specific immunoglobulin and virus-specific immunoglobulin G titers did not vary by more than one twofold dilution when compared by the two methods. Efforts are being made to develop a reliable calf serum, penicillin (100 U/ml) streptomycin radioimmunoassay (RIA) for the detection of (100 ,ug/ml), and 0.1% bicarbonate, were in- virus-specific immunoglobulins, acceptable for fected with the isolated virus. Uninoculated use in diagnostic serology (1, 2, 5-8). The estab- monolayers were maintained as controls. When lishment of a satisfactory RIA depends on the infected monolayers showed 75% cytopathic use of antibody with both a high avidity and effect, both inoculated and uninoculated cells selectivity for the material to be assayed (4). were dispersed, using 0.015% ethylenediamine- Consequently, a major obstacle to using RIA tetraacetic acid. Both cellular suspensions were routinely is the necessity of preparing specific standardized to contain 2.5 x 105 cells/ml in high-titer antibody against human immuno- phosphate-buffered saline. Using 0.025-ml vol- globulins (IgG, IgM, and IgA).
    [Show full text]
  • Allergy Skin and Challenge Testing
    Corporate Medical Policy Allergy Skin and Challenge Testing File Name: allergy_skin_and_challenge_testing Origination: 7/1979 Last CAP Review: 11/2020 Next CAP Review: 11/2021 Last Review: 11/2020 Description of Procedure or Service Management of the allergic patient may include identifying the offending agent by means of allergy testing. Allergy testing can be broadly grouped into in vivo and in vitro methodologies: • In vivo testing - includes allergy skin testing such as the scratch, puncture or prick test (epicutaneous), intradermal test (intracutaneous) and patch test, and food and bronchial challenges. • In vitro testing - includes various techniques to test the blood for the presence of specific IgE antibodies to a particular antigen. Once the agent is identified, treatment is provided by avoidance, medication or immunotherapy (allergy shots). Allergic or hypersensitivity disorders may be manifested by generalized systemic reactions as well as by localized reactions in any organ system of the body. The reactions may be acute, subacute, or chronic, immediate or delayed, and may be caused by numerous offending agents: pollen, molds, dust mites, animal dander, stinging insect venoms, foods, drugs, etc. This policy only addresses in vivo (skin and challenge) testing; for vitro testing, see policy titled, Allergen Testing. Related Policies: Allergy Immunotherapy Desensitization Allergen Testing AHS – G2031 Maximum Units of Service Idi ***Note: This Medical Policy is complex and technical. For questions concerning the technical language and/or specific clinical indications for its use, please consult your physician. Policy BCBSNC will provide coverage for Allergy skin and challenge testing when it is determined to be medically necessary because the medical criteria and guidelines shown below are met.
    [Show full text]
  • Guidance and Protocol for the Serological Diagnosis of Human Infection with Bordetella Pertussis
    TECHNICAL DOCUMENT Guidance and protocol for the serological diagnosis of human infection with Bordetella pertussis As part of the EUpert-Labnet surveillance network www.ecdc.europa.eu ECDC TECHNICAL DOCUMENT Guidance and protocol for the serological diagnosis of human infection with Bordetella pertussis As part of the EUpert-Labnet surveillance network This report was commissioned by the European Centre for Disease Prevention and Control (ECDC), coordinated by Adoracion Navarro Torne, and produced by the members of the European Bordetella expert group ‘EUpert-Labnet’ as part of the project contract: Coordination of activities for laboratory surveillance of whooping cough in Member States and EEA countries (OJ/26/05/2011-PROC/2011/037) Authors Marion Riffelmann, HELIOS Kinikum Krefeld, Germany; Carl Heinz Wirsing von König, HELIOS Kinikum Krefeld, Germany; Dorothy Xing, National Institute for Biological Standards and Control (NIBSC), Health Protection Agency, Potters Bar, United Kingdom; Qiushui He, National Institute for Health and Welfare (THL), Turku, Finland. This protocol is intended to serve as a starting point for laboratories aiming at introducing ELISA serology for diagnosis of human Bordetella pertussis infections. Comments, requests or questions can be addressed to the authors. Version 1.0, October 2012 Disclaimer: this technical guidance is based on the latest available published data on diagnostic test performance at the time of writing. ECDC does not endorse any particular commercial product or instrument. Suggested citation:
    [Show full text]
  • UBI® SARS-Cov-2 ELISA INSTRUCTIONS for USE
    UBI® SARS-CoV-2 ELISA INSTRUCTIONS FOR USE FOR IN VITRO DIAGNOSTIC USE ONLY FOR EMERGENCY USE AUTHORIZATION ONLY FOR PRESCRIPTION USE ONLY INTENDED USE The UBI® SARS-CoV-2 ELISA is an Enzyme-Linked Immunosorbent Assay (ELISA) intended for qualitative detection of IgG antibodies to SARS-CoV-2 in human serum and plasma (sodium heparin or dipotassium (K2) EDTA). The UBI® SARS-CoV-2 ELISA is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. At this time, it is unknown for how long antibodies persist following infection and if the presence of antibodies confers protective immunity. The UBI® SARS-CoV-2 ELISA should not be used to diagnose or exclude acute SARS-CoV-2 infection. Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C 263a, that meet requirements to perform high complexity testing. Results are for the detection of IgG SARS CoV-2 antibodies. IgG antibodies to SARS-CoV-2 are generally detectable in blood several days after initial infection, although the duration of time antibodies are present post-infection is not well characterized. Individuals may have detectable virus present for several weeks following seroconversion. Laboratories within the United States and its territories are required to report all results to the appropriate public health authorities. The sensitivity of the UBI® SARS-CoV-2 ELISA early after infection is unknown. Negative results do not preclude acute SARS-CoV-2 infection. If acute infection is suspected, direct testing for SARS-CoV-2 is necessary.
    [Show full text]
  • FOR REFERENCE USE ONLY: DO NOT USE in Place of Package Inserts Provided with Each Product
    [US] • Isotonic saline solution Coombscell-E IgG-coated Red Blood Cells for the control of the antiglobulin Coombscell-E is a single vial of group 0 red blood cells sensitized with human test monoclonal IgG antibodies (specificity anti-D). • Reagent Red Blood Cells: Biotest: Biotestcell® 1 & 2 [REF] 816014100, FOR IN-VITRO DIAGNOSTIC USE ® Biotestcell® 3 [REF] 816085100, Biotestcell -I 8 [REF] 816020100, For tube test ® Biotestcell -I 11 [REF] 816021100 Package size • Donor or patient red blood cells [REF] 816030100 [VOL] 10 mL Coombscell-E • MLB 2 (Modified LISS Biotest) [REF] 8065200100 • Anti-Human Globulin Anti-IgG [REF] 804175100 • Anti-Human Globulin Anti-IgG, -C3d Polyspecific [REF] 804115100 Intended Use Coombscell-E Red Blood Cells are used for • Glass tubes 10 x 75mm or 12 x 75mm • in-house quality control (reactivity control of Anti-Human-Globulin) • Serological centrifuge • to control the technique of antiglobulin-test with negative results • Interval Timer to verify the negative results of the IAT (Indirect Antiglobulin Test) and DAT • Markers (Direct Antiglobulin Test) • Optical aid (optional). The use of an optical aid for agglutination reading must be vaildated by the user. Summary Moreschi first described the use of Anti-Human Globulin in 19081. Coombs Test procedure rediscovered the test in 1945.2,3 By injecting rabbits with human IgG, they A. Tube test were able to produce a protein (Anti-IgG) that reacted with incomplete antibodies (IgG). Most “incomplete” antibodies (IgG) fail to agglutinate red Verification of negative result in antiglobulin test blood cells suspended in saline.4 Most clinically significant antibodies in red 1.
    [Show full text]
  • Switching from RIA to ELISA
    Switching from RIA to ELISA Being able to quantify biomarkers in a complex sample such as serum, cell culture media or even urine is of the utmost importance in biomarker research. Immunoassays that utilize highly specific the possibility of it measuring proglucagon-derived antibodies to detect biomarkers and analyze their peptides other than glucagon cannot be ruled out. concentration in such samples have been around An independent study has assessed the Mercodia since 1959 when Yalow and Berson first used sandwich ELISA and found it to be the most radiolabeled insulin to assess the concentration reliable assay for measuring glucagon3. of insulin in humans1. This radioimmunoassay (RIA) was followed by a new technique in 1971 when Engvall and Perlman developed an assay Pros and Cons where antigens immobilized on a microplate well are incubated with the sample and the Both ELISA and RIA can be used to measure concentration of the biomarker of interest glucagon, but the latter format is often based quantified using an enzyme-linked on a polyclonal antibody and may thus show anti-immunoglobulin antibody2. This method cross-reactivities to substances other than the is called enzyme-linked immunosorbent test analyte, such as hemoglobin and bilirubin. assay (ELISA). A sandwich ELISA, on the other hand, is based on two antibodies, which ensures high specificity for Since then, RIAs and ELISAs have been used the analyte. Mercodia ELISA assays are all based extensively to detect and quantify biomarkers. on monoclonal antibodies, so reproducibility There are, however, differences between the two between lots is assured. technologies that should be considered when comparing the two types and selecting an assay In addition, ELISA’s enzyme-based detection format.
    [Show full text]
  • Enzyme Immunoassay and Enzyme-Linked Immunosorbent Assay Stephanie D
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector RESEARCH TECHNIQUES MADE SIMPLE Enzyme Immunoassay and Enzyme-Linked Immunosorbent Assay Stephanie D. Gan1 and Kruti R. Patel2 Journal of Investigative Dermatology (2013) 133, e12. doi:10.1038/jid.2013.287 INTRODUCTION Enzyme immunoassay (EIA) and enzyme-linked immunosor- WHAT ENZYME-LINKED bent assay (ELISA) are both widely used as diagnostic tools in IMMUNOSORBENT ASSAY (ELISA) DOES medicine and as quality control measures in various industries; • ELISA is a biochemical assay that uses antibodies they are also used as analytical tools in biomedical research and an enzyme-mediated color change to detect for the detection and quantification of specific antigens or anti- the presence of either antigen (proteins, peptides, bodies in a given sample. These two procedures share similar hormones, etc.) or antibody in a given sample. basic principles and are derived from the radioimmunoassay (RIA). RIA was first described by Berson and Yalow (Yalow and • Both “indirect” and “sandwich” ELISAs allow Berson, 1960), for which Yalow was awarded the Nobel Prize detection of antigen or antibody at very low in 1977, to measure endogenous plasma insulin. RIA was then concentrations. developed into a novel technique to detect and measure bio- • The competitive method detects compositional logical molecules present in very small quantities, paving the differences in complex antigen mixtures with way for the analysis and detection of countless other biologi- high sensitivity, even when the specific detecting cal molecules, including hormones, peptides, and proteins. antibody is present in relatively small amounts.
    [Show full text]
  • Making Antibodies Work
    MILESTONES conjugated to the enzyme alkaline MILESTONE 4 phosphatase. They named their assay the ‘enzyme-linked immuno­sorbent assay’, which resulted in the catchy Making antibodies acronym ‘ELISA’. In addition to its application in the detection and work quantification of serum components, ELISAs are routinely used to detect viral infections, such as infection with human immunodeficiency virus, and the technique remains a mainstay of laboratories around the world. In addition to detecting the tagging of antibodies to molecules or cells of interest, it was clearly desira- ble to be able to separate the tagged components. This was achieved in Crossed immunoelectropho- 1979 by David Parks, Virginia Bryan, resis—just one analytical application of antibodies— Vernon Oi and Leonard Herzenberg, can simultaneously identify who used the newly invented dozens of serum proteins. Courtesy T.C.Bøg-Hansen. fluorescence-­activated cell sorter. The light-scattering and fluorescent prop- erties of the cells enabled cells bound with antigen-coupled microspheres to be distinguished and directed Because antibodies are able to between the binding of antibodies into alternative collection pots, thus specifically bind target molecules, to endogenous insulin versus their facilitating phenotypic separation, the possibility of their having an binding to radioactive insulin. This monoclonal description and categorization. analytical application was recognized radioimmunoassay was used to antibodies… Since the pioneering work of early on. Robin Coombs, Arthur measure insulin present in the blood César Milstein and Georges J. F. Mourant and Robert Race, working and provided greater sensitivity than have had Köhler (MILESTONE 9) there have for the UK’s Medical Research that of previous approaches.
    [Show full text]